Results 261 to 270 of about 155,886 (352)

The effect of β-glucan on the glycemic and insulin index

open access: bronze, 2006
H. Mäkeläinen   +7 more
openalex   +1 more source

Starch digestion and physiochemical properties of a newly developed rice variety with low glycemic index. [PDF]

open access: yesFood Chem X
Liao C   +8 more
europepmc   +1 more source

A geriatrician's approach to managing the complex older adult with obesity

open access: yesObesity, EarlyView.
Abstract The prevalence of obesity in older adults is rapidly increasing due to the demographic shift occurring globally. Older adults with obesity face health care challenges due to multimorbidity, functional dependency, and disability. This population often has prior history of struggles through weight‐loss attempts during the middle years of life ...
Shenbagam Dewar
wiley   +1 more source

Can the Glycemic Index (GI) be Used as a Tool in the Prevention and Management of Type 2 Diabetes?

open access: bronze, 2006
Marie‐Louise From Hermansen   +4 more
openalex   +1 more source

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

Development of Whole-Grain Rice Lines Exhibiting Low and Intermediate Glycemic Index with Decreased Amylose Content. [PDF]

open access: yesFoods
Chaichoompu E   +10 more
europepmc   +1 more source

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial

open access: yesObesity, EarlyView.
ABSTRACT Objective This study aimed to evaluate the added effect of acarbose to orlistat on relative weight loss in the novel antiobesity medication EMP16. Methods In this 6‐month double‐blind trial, 240 individuals with obesity or overweight and comorbidities were randomized equally into three groups: (1) EMP16 (120 mg modified release orlistat/40 mg ...
Ulf Holmbäck   +7 more
wiley   +1 more source

Effect of a Low Glycemic Index/Slow Digesting (LGI/SD) Carbohydrate Product on Maternal Glycemia and Neonatal Body Composition in Obese Pregnant Women: The NIGOHealth Randomized Clinical Trial. [PDF]

open access: yesNutrients
G Bermúdez M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy